Emv Capital (EMVC)

Sector:

Financials

Index:

FTSE AIM All-Share

43.50p
   
  • Change Today:
    -2.50p
  • 52 Week High: 58.00p
  • 52 Week Low: 36.50p
  • Currency: UK Pounds
  • Shares Issued: 27.77m
  • Volume: 22,436
  • Market Cap: £12.08m

NetScientific subsidiary Wanda improve patient assistance software

By Duncan Ferris

Date: Wednesday 18 Jul 2018

LONDON (ShareCast) - (Sharecast News) - Healthcare IP commercialisation firm NetScientific on Wednesday announced that portfolio company Wanda has completed a major enhancement of its patient management platform.
Wanda, in which AIM traded firm NetScientific holds a 62% stake on a fully diluted basis, has an existing platform which has been shown to predict 90% of patient-level adverse events up to seven days in advance of their occurrence, according to NetScientific.

The new system includes personalised reminders and alerts, which can be pre-scheduled and delivered to patients via multi-modal communications, and a cloud text-to-speech application programming interface from Google that uses machine learning to deliver natural-sounding human voice automation.

A company statement said the changes provide a "highly intelligent method" to avoid the costs of unplanned readmissions and emergency department visits due to nonadherence.

Francois Martelet, NetScientific's chief executive and chairman of Wanda, said: "Wanda's enhancements to its core technology mean that relationships between clinicians and patients will continue to improve, and will empower patients to take a more active role in the management of their diseases as well as increase their quality of life."

NetScientific's shares were down 1.33% at 38.00p at 1435 BST.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Emv Capital Market Data

Currency UK Pounds
Share Price 43.50p
Change Today -2.50p
% Change -5.43 %
52 Week High 58.00p
52 Week Low 36.50p
Volume 22,436
Shares Issued 27.77m
Market Cap £12.08m

Emv Capital Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.56% above the market average18.56% above the market average18.56% above the market average18.56% above the market average18.56% above the market average
6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average
Price Trend
52.21% below the market average52.21% below the market average52.21% below the market average52.21% below the market average52.21% below the market average
62.38% below the sector average62.38% below the sector average62.38% below the sector average62.38% below the sector average62.38% below the sector average
Income Not Available
Growth
12.68% above the market average12.68% above the market average12.68% above the market average12.68% above the market average12.68% above the market average
13.98% above the sector average13.98% above the sector average13.98% above the sector average13.98% above the sector average13.98% above the sector average

Emv Capital Dividends

No dividends found

Trades for 28-Aug-2025

Time Volume / Share Price
14:55 503 @ 44.70p
13:39 2,210 @ 44.70p
11:50 2,223 @ 44.80p
11:49 9,000 @ 44.00p
11:45 8,500 @ 44.55p

Emv Capital Key Personnel

CEO Ilian Iliev
CFO Stephen Crowe

Top of Page